This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Dec;30(12):606-8.

doi: 10.1159/000111479. Epub 2007 Nov 30.

Five years of clinical experience with metronomic chemotherapy: achievements and perspectives

Urban Emmenegger, Robert S Kerbel

PMID: 18063872
DOI: 10.1159/000111479

Free article

Editorial

Five years of clinical experience with metronomic chemotherapy: achievements and perspectives

Urban Emmenegger et al. Onkologie. 2007 Dec.

Free article

. 2007 Dec;30(12):606-8.

doi: 10.1159/000111479. Epub 2007 Nov 30.

Authors

Urban Emmenegger, Robert S Kerbel

PMID: 18063872
DOI: 10.1159/000111479

No abstract available

PubMed Disclaimer

Comment on

Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study.
Steinbild S, Arends J, Medinger M, Häring B, Frost A, Drevs J, Unger C, Strecker R, Hennig J, Mross K. Steinbild S, et al. Onkologie. 2007 Dec;30(12):629-35. doi: 10.1159/000110580. Epub 2007 Nov 30. Onkologie. 2007. PMID: 18063875 Clinical Trial.

Similar articles

[Metronomic chemotherapy in 2011: update and perspectives].
Benbrahim Z, Massard C, El Mesbahi O. Benbrahim Z, et al. Bull Cancer. 2011 Dec;98(12):1447-54. doi: 10.1684/bdc.2011.1493. Bull Cancer. 2011. PMID: 22146261 Review. French.
Metronomic chemotherapy: teaching old drugs new tricks?
Vogelzang N. Vogelzang N. Clin Adv Hematol Oncol. 2004 Jul;2(7):432-3. Clin Adv Hematol Oncol. 2004. PMID: 16163217 No abstract available.
Metronomic chemotherapy: Back to the future!
André N, Padovani L, Verschuur A. André N, et al. Drug News Perspect. 2010 Mar;23(2):143-51. doi: 10.1358/dnp.2010.23.2.1475913. Drug News Perspect. 2010. PMID: 20369080 Review.
Can a rational design for metronomic chemotherapy dosing be devised?
Maraveyas A, Lam T, Hetherington JW, Greenman J. Maraveyas A, et al. Br J Cancer. 2005 Apr 25;92(8):1588-90. doi: 10.1038/sj.bjc.6602474. Br J Cancer. 2005. PMID: 15846302 Free PMC article. No abstract available.
Hitting the mother lode of tumor angiogenesis.
James D, Rabbany S, Rafii S. James D, et al. Nat Biotechnol. 2008 Jul;26(7):769-70. doi: 10.1038/nbt0708-769. Nat Biotechnol. 2008. PMID: 18612297 Free PMC article. No abstract available.

See all similar articles

Cited by

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.
Ma J, Waxman DJ. Ma J, et al. Mol Cancer Ther. 2008 Dec;7(12):3670-84. doi: 10.1158/1535-7163.MCT-08-0715. Mol Cancer Ther. 2008. PMID: 19074844 Free PMC article. Review.
Capecitabine "metronomic" chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy.
He S, Shen J, Hong L, Niu L, Niu D. He S, et al. Med Oncol. 2012 Mar;29(1):100-6. doi: 10.1007/s12032-010-9791-x. Epub 2011 Jan 25. Med Oncol. 2012. PMID: 21264547 Clinical Trial.
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept.
De Lorenzo S, Tovoli F, Barbera MA, Garuti F, Palloni A, Frega G, Garajovà I, Rizzo A, Trevisani F, Brandi G. De Lorenzo S, et al. Sci Rep. 2018 Jul 3;8(1):9997. doi: 10.1038/s41598-018-28337-6. Sci Rep. 2018. PMID: 29968763 Free PMC article.
Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.
Maur M, Omarini C, Piacentini F, Fontana A, Pettorelli E, Cascinu S. Maur M, et al. Am J Case Rep. 2017 Feb 28;18:208-211. doi: 10.12659/ajcr.901812. Am J Case Rep. 2017. PMID: 28242865 Free PMC article. Review.
Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer.
Reynolds AR. Reynolds AR. Dose Response. 2010 Apr 23;8(3):253-84. doi: 10.2203/dose-response.09-049.Reynolds. Dose Response. 2010. PMID: 20877487 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- S. Karger AG, Basel, Switzerland
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information